4
Changes in Ownership
Inspire Medical Systems, Inc. Filed Acc 0001104659-24-114302
Chief Technology Officer sold 8,703 shares at an average $193.47 ($1,683,731)
- Chief Technology Officer acquired 8,703 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rondoni John Chief Technology Officer | 2024-11-01 | Option exercise 10b5-1 | +5,802 | $71.00 | $411,942 | 17,150 | D: show line 1 in the form |
| Rondoni John Chief Technology Officer | 2024-11-01 | Option exercise 10b5-1 | +2,901 | $42.15 | $122,277 | 20,051 | D: show line 2 in the form |
| Rondoni John Chief Technology Officer | 2024-11-01 | Sale 10b5-1 | −5,777 | $192.93 | $1,114,557 | 14,274 | D: show line 3 in the form |
| Rondoni John Chief Technology Officer | 2024-11-01 | Sale 10b5-1 | −1,580 | $193.92 | $306,394 | 12,694 | D: show line 4 in the form |
| Rondoni John Chief Technology Officer | 2024-11-01 | Sale 10b5-1 | −1,013 | $194.84 | $197,373 | 11,681 | D: show line 5 in the form |
| Rondoni John Chief Technology Officer | 2024-11-01 | Sale 10b5-1 | −333 | $196.42 | $65,408 | 11,348 | D: show line 6 in the form |
| Open-market sales · 8,703 sh · avg $193.47 · $1,683,731 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Rondoni John Chief Technology Officer | 2024-11-01 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −5,802 | 1,448 | D: show line 7 in the form | |||||
| Rondoni John Chief Technology Officer | 2024-11-01 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −2,901 | 9,197 | D: show line 8 in the form |
Loading xslF345X05/tm2427544-1_4seq1.xml…